Gentamicin reduces serum ACE activity in patients with normal kidney function

American Journal of Nephrology

Volumn 22, Issue 5-6, 2002, Pages 487-490

  Ziai, Seyed Ali ^a   Mooraki, Ahmed ^a   Mahmoudian, Massoud ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin converting enzyme; Creatinine; Gentamicin; NAG; Nephrotoxicity

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; GENTAMICIN; N ACETYL BETA GLUCOSAMINIDASE; POTASSIUM; SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FRACTURE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; MALE; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

ACETYLGLUCOSAMINIDASE; ADULT; BIOLOGICAL MARKERS; CREATININE; FRACTURES, BONE; GENTAMICINS; HUMANS; KIDNEY; PEPTIDYL-DIPEPTIDASE A;

EID: 0036977326     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065282     Document Type: Article

References (26)

1. Kidwell DT, McKeown JW, Grider JS, McCombs GB, Ott CE, Jackson BA: Acute effects of gentamicin on thick ascending limb function in the rat. Eur J Pharmacol 1994;270:97-103.
2. Soffer RL: Angiotensin converting enzyme and the regulation of vasoactive peptides. Ann Rev Biochem 1976;45:73-94.
3. Leiberman J: Elevation of serum angiotensin converting enzyme (ACE) levels in sarcoidosis. Am J Med 1975;59:365-372.
4. Leiberman J, Beutler E: Elevation of serum angiotensin converting enzyme in Gaucher's disease. N Engl J Med 1976;294:1442-1444.
5. Nokamura Y, Takeda T, Ishi M, Nishiyama K, Yamekada M, Hirata Y, Kimua K, Murao S: Elevation of serum angiotensin converting enzyme in patients with hyperthyroidism. J Clin Endocrinol Metab 1982;55:931-934.
6. Bianchini G, Letizia C, Domenici A, Scavo D: The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin converting enzyme before and after treatment. Drug Exp Clin Res 1991;17:263-269.
7. Nielsen AH, Knudsen F, Kristensen SD: Serum angiotensin converting enzyme increase during hemodialysis: Evidence for injury of the pulmonary vascular endothelium? Nephron 1985;40:100-103.
8. Kramer BK, Ulshofer T, Ress KM, Muller GA, Risler T: Serum angiotensin converting enzyme is not an indicator of dialyzer membrane biocompatibility. Nephron 1989;53:162-163.
9. Romer FK, Schmitz O: Angiotensin converting enzyme activity in renal disorders: Influence of disease pattern, hemodialysis and transplantation. Clin Nephrol 1984;21:178-183.
10. Morin JP, Thomas N, Toutain H, Borghi H, Fillastre JP: Modulation of gentamicin nephrotoxicity by chronic inhibition of angiotensin I-converting enzyme in rat. Arch Toxicol 1989;63:47-53.
11. Ziai SA, Sadeghian T, Soltani-Arabshahi SK, Mahmoudian M: Determination of angiotensin converting enzyme (ACE) activity in healthy Iranian population: relationship to paraclinical parameters and cigarette smoking. Res Commun Alcoh Subst Abuse 1999;20:99-111.
12. Horak E, Hopfer SM, Sunderman FW: Spec-trophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem 1981;27:1180-1185.
13. De Broe ME, Paulus GJ, Verpooten GA, Roels F, Buyssens N, Wedeen R, Van Hoof F, Tulkens PM: Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kidney Int 1984;25:643-652.
14. Smith CR, Lipsky JJ, Laskin OL, Hellmann DB, Hellits ED, Longstreth J, Lietman P: Double blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 1980;302:1106-1109.
15. Fong IW, Fenton RS, Bird R: Comparative toxicity of gentamicin versus tobramycin: A randomized prospective study. J Antimicrob Chemother 1981;7:81-88.
16. Pedraza-Chaverri J, Ivette Moreno-Muniz S, Cruz C, Hernandez-Pando R, Larriva-Sahd J, Tapia E: Urinary angiotensin I-converting enzyme activity is increased in experimental acute renal failure. Clin Invest Med 1995;18:424-434.
17. Pedraza-Chaverri, J, Cruz C, Hernandez-Pando R, Santana T, Arevalo A, Gonzalez L, Tapia E, Pena J, Panduro A: Angiotensin I-converting enzyme activity in rats with carbon tetrachloride-induced acute renal failure. Renal Fail 1993;15:19-26.
18. Pedraza-Chaverri J, Cruz C, Balancas M, Hernandez-Pando R, Ibarra-Rubio M, Larriva-Sahd J, Tapia E: Angiotensin I converting enzyme activity in uranyl nitrate induced acute renal failure in rats. Renal Fail 1995;17:377-388.
19. Pedraza-Chaverri J, Maciel AH, Cruz C, Pena J: Captopril magnifies the increase in the angiotensin I-converting enzyme activity in rats with aminonucleoside nephrosis. Clin Exp Pharmacol Physiol 1992;19:439-445.
20. Arevalo AE, Ibarra-Rubio ME, Cruz C, Pena JC, Pedraza-Chavverri J: Angiotensin I-converting activity in puromycin aminonucleoside-nephrotic syndrome. Clin Chim Acta 1990;191:175-184.
21. Marchewka Z, Kuzniar J, Lembas-Bogaczyk J, Jacyszin K: N-acetyl-B-D-glucosaminidase isoenzymes in the diagnosis of poisoning and kidney disease. Int Urol Nephrol 1994;26:229-236.
22. Lockwood TD, Bosman HB: The use of urinary N- Acetyl-b-glucosaminidase in human renal toxicology. I. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney. Toxicol Appl Pharmacol 1979;49:323-336.
23. Lockwood TD, Bosman HB: The use of urinary N-acetyl-b-glucosaminidase in human renal toxicology. II. Elevation in human excretion after aspirin and sodium salicylate. Toxicol Appl Pharmacol 1979;49:337-345.
24. Alhenc-Gelas F, Weare JA, Johnson RL, Erdos EG: Measurement of human converting enzyme level by direct radioimmunoassay. J Lab Clin Med 1983;101:83-96.
25. Alhenc-Gelas F, Richard J, Courbon D, War-net JM, Corvol P: Distribution of plasma angiotensin I-converting enzyme in healthy men. Relationship to environmental and hormonal parameters. J Lab Clin Med 1991;117:33-39.
26. Ziai SA, Seyedhosseini D, Taiebi L, Salekmoghadam E, Mahmoudian M: Correlation between ACE activity and mean blood pressure in Iranian normotensive subjects after oral administration of a single dose of enalapril. Acta Physiol Hung 2000;87:153-159.